Betamethasone Dipropionate

Product NDC
0168-0265
11-digit product format
001680265
Labeler code
0168
Product ID
0168-0265_98a5f88e-6ba5-4064-b851-17b63a13e883
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Betamethasone dipropionate
Dosage form
CREAM, AUGMENTED
Route
TOPICAL
Labeler
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
Application
ANDA076215
Marketing category
ANDA
Marketing start
2003-12-09
Marketing end
0000-00-00
Substance
BETAMETHASONE DIPROPIONATE
Active strength
1 mg/g
Pharmacologic classes
Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0168-0265DDiscontinued by firm2026-08-17
excluded packagepackage0168-02650168-0265-15DDiscontinued by firm2026-08-17
excluded packagepackage0168-02650168-0265-50DDiscontinued by firm2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 21 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0168-0265-15DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0168-0265-50DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0168-0265-15DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0168-0265-50DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductDDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0168-0265-15DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0168-0265-50DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductDDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0168-0265-15DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0168-0265-50DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductDDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0168-0265-15DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0168-0265-50DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductDDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0168-0265-15DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0168-0265-50DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproductIInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage0168-0265-50IInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage0168-0265-15IInactivated by FDAe2bbac7714bc…27bdfed8d636…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A076215-001BETAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A076215-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-0931067a03dcf5…
2025-08-23 18:47 UTC2025-08A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-096a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-0903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-092680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-095bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-0979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-091e350fbaab3a…
2024-05-31 18:47 UTC2024-05A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-098072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-095c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-095d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-094b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-0974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-0987673890dc5c…
2021-03-12 10:30 UTC2021-03A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-095aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-098869cabd3fbd…
2020-11-12 02:37 UTC2020-11A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09c0c555d07b60…
2019-12-14 00:12 UTC2019-12A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-093f01610625f2…
2019-09-15 20:21 UTC2019-09A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09b00525d2431f…
2019-07-19 19:46 UTC2019-07A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-096a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-091c564ffb4f44…
2023-12-20 04:57 UTC2023-12A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-099b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-093f0d92c62455…
2023-05-13 08:27 UTC2023-05A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09053a50430f4f…
2023-01-26 05:58 UTC2023-01A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-093bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-093a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A076215-001BETAMETHASONE DIPROPIONATEEQ 0.05% BASECREAM, AUGMENTED / TOPICALAB2003-12-09e64feba35796…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A076215-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A076215-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076215-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A076215-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076215-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076215-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076215-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076215-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A076215-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A076215-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A076215-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A076215-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A076215-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A076215-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A076215-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A076215-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A076215-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A076215-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A076215-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A076215-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A076215-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A076215-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A076215-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A076215-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A076215-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A076215-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A076215-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A076215-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A076215-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A076215-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A076215-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A076215-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A076215-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A076215-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A076215-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A076215-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A076215-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A076215-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A076215-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A076215-001AB1e64feba35796…

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
0168-0265-152020-12-07These highlights do not include all the information needed to use. BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented). BETAMETHASONE DIPROPIONATE cream, 0.05 % (augmented) for topical use Initial U.S. Approval: 1983
0168-0265-502020-12-07These highlights do not include all the information needed to use. BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented). BETAMETHASONE DIPROPIONATE cream, 0.05 % (augmented) for topical use Initial U.S. Approval: 1983
0168-0265-152020-09-27These highlights do not include all the information needed to use. BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented). BETAMETHASONE DIPROPIONATE cream, 0.05 % (augmented) for topical use Initial U.S. Approval: 1983
0168-0265-502020-09-27These highlights do not include all the information needed to use. BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented). BETAMETHASONE DIPROPIONATE cream, 0.05 % (augmented) for topical use Initial U.S. Approval: 1983
0168-0265-152020-09-25These highlights do not include all the information needed to use. BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented). BETAMETHASONE DIPROPIONATE cream, 0.05 % (augmented) for topical use Initial U.S. Approval: 1983
0168-0265-502020-09-25These highlights do not include all the information needed to use. BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented). BETAMETHASONE DIPROPIONATE cream, 0.05 % (augmented) for topical use Initial U.S. Approval: 1983
0168-0265-152020-07-22These highlights do not include all the information needed to use. BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented). BETAMETHASONE DIPROPIONATE cream, 0.05 % (augmented) for topical use Initial U.S. Approval: 1983
0168-0265-502020-07-22These highlights do not include all the information needed to use. BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Cream, 0.05% (Augmented). BETAMETHASONE DIPROPIONATE cream, 0.05 % (augmented) for topical use Initial U.S. Approval: 1983

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0168-0265-15GM - Gram0168-0265dd1b5e6a-735e-4e5d-ae16-3667b06b3dce12012-07-24
0168-0265-50GM - Gram0168-02654db48579-957b-42d4-a1d0-9027ddc1568412012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BETAMETHASONE DIPROPIONATEACTIVE INGREDIENT826Y60901UBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
BETAMETHASONEACTIVE MOIETY9842X06Q6MBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)INACTIVE INGREDIENT4Q93RCW27EBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
CETEARETH-30INACTIVE INGREDIENT1R9DCZ5FOXBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
CHLOROCRESOLINACTIVE INGREDIENT36W53O7109BETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
CYCLOMETHICONEINACTIVE INGREDIENTNMQ347994ZBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
GLYCERYL OLEATEINACTIVE INGREDIENT4PC054V79PBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
PETROLATUMINACTIVE INGREDIENT4T6H12BN9UBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3BETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
SORBITOLINACTIVE INGREDIENT506T60A25RBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
WATERINACTIVE INGREDIENT059QF0KO0RBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
WHITE WAXINACTIVE INGREDIENT7G1J5DA97FBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
BETAMETHASONE DIPROPIONATEACTIVE INGREDIENT826Y60901UBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
BETAMETHASONEACTIVE MOIETY9842X06Q6MBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)INACTIVE INGREDIENT4Q93RCW27EBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
CETEARETH-30INACTIVE INGREDIENT1R9DCZ5FOXBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
CHLOROCRESOLINACTIVE INGREDIENT36W53O7109BETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
CYCLOMETHICONEINACTIVE INGREDIENTNMQ347994ZBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
GLYCERYL OLEATEINACTIVE INGREDIENT4PC054V79PBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
PETROLATUMINACTIVE INGREDIENT4T6H12BN9UBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3BETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
SORBITOLINACTIVE INGREDIENT506T60A25RBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
WATERINACTIVE INGREDIENT059QF0KO0RBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1
WHITE WAXINACTIVE INGREDIENT7G1J5DA97FBETAMETHASONE DIPROPIONATE CREAM, AUGMENTED [PROFICIENT RX LP]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0168-0265-150016802651515 g in 1 TUBE (0168-0265-15) 15 g2003-12-090000-00-00NoNoCurrent
0168-0265-500016802655050 g in 1 TUBE (0168-0265-50) 50 g2003-12-090000-00-00NoNoCurrent